Esophageal Carcinoma
Conditions
Interventions
Esophageal cancer treated directly with surgery group:None
Esophageal cancer undergoing surgery after neoadjuvant therapy group:None
Esophageal cancer on a wait-and-see strategy after neoadjuvant therapy group:None
Esophageal cancer undergoing radical chemoradiotherapy (or combination immunotherapy) group:None
Sponsors
Xijing Hospital, Air Force Medical University (PLA)
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1) The age of initial diagnosis is 18-75 years old; 2) Esophageal cancer, with complete case data, clear pathological diagnosis information and staging information; 3) No history of malignant tumors in other parts of the past; 4) There were no metastases in liver, lung or other parts of the imaging examination; 5) Have not received surgery, chemotherapy or radiotherapy, PD-1/PD-L1 immunotherapy before enrollment.
Exclusion criteria
Exclusion criteria: 1) Life expectancy less than 6 months; 2) Patients with no ability to make independent decisions or mental illness; 3) Any other situation that the investigator deems inappropriate to participate in this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Multi-gene methylation levels; | — |
Secondary
| Measure | Time frame |
|---|---|
| Tumor Markers;Imaging Examinations; | — |
Countries
China
Contacts
Public ContactHong liu
Xijing Hospital, Air Force Medical University (PLA)
Outcome results
None listed